171 related articles for article (PubMed ID: 22129902)
1. Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses.
Filipović Grčić P; Matijaca M; Lušić I; Čapkun V
Med Sci Monit; 2011 Dec; 17(12):CR704-10. PubMed ID: 22129902
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.
Skov CD; Sørensen CB; Thorning M; Lambertsen KL; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
Mult Scler Relat Disord; 2022 Oct; 66():104034. PubMed ID: 35843140
[TBL] [Abstract][Full Text] [Related]
3. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
[TBL] [Abstract][Full Text] [Related]
4. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Burton JM; O'Connor PW; Hohol M; Beyene J
Cochrane Database Syst Rev; 2012 Dec; 12():CD006921. PubMed ID: 23235634
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
Nos C; Sastre-Garriga J; Borràs C; Río J; Tintoré M; Montalban X
Mult Scler; 2004 Aug; 10(4):413-6. PubMed ID: 15327039
[TBL] [Abstract][Full Text] [Related]
6. Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.
Filipović Grčić P; Matijaca M; Bilić I; Džamonja G; Lušić I; Čaljkušić K; Čapkun V
Acta Neurol Belg; 2013 Dec; 113(4):397-402. PubMed ID: 23494833
[TBL] [Abstract][Full Text] [Related]
7. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
Liu S; Liu X; Chen S; Xiao Y; Zhuang W
PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Yamasaki R; Matsushita T; Fukazawa T; Yokoyama K; Fujihara K; Ogino M; Yokota T; Miyamoto K; Niino M; Nomura K; Tomioka R; Tanaka M; Kawachi I; Ohashi T; Kaida K; Matsui M; Nakatsuji Y; Ochi H; Fukaura H; Kanda T; Nagaishi A; Togo K; Mizusawa H; Murai H; Kira J
Mult Scler; 2016 Sep; 22(10):1337-48. PubMed ID: 26564994
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
11. Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.
Sandroff BM; Motl RW; Sosnoff JJ; Pula JH
Gait Posture; 2015 Jan; 41(1):222-7. PubMed ID: 25455207
[TBL] [Abstract][Full Text] [Related]
12. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
Fritz NE; Jiang A; Keller J; Zackowski KM
Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response.
Evangelopoulos ME; Nasiri-Ansari N; Kassi E; Papadopoulou A; Evangelopoulos DS; Moutsatsou P
Sci Rep; 2021 Sep; 11(1):19462. PubMed ID: 34593869
[TBL] [Abstract][Full Text] [Related]
14. Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.
Block VJ; Bove R; Zhao C; Garcha P; Graves J; Romeo AR; Green AJ; Allen DD; Hollenbach JA; Olgin JE; Marcus GM; Pletcher MJ; Cree BAC; Gelfand JM
JAMA Netw Open; 2019 Mar; 2(3):e190570. PubMed ID: 30874777
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
[TBL] [Abstract][Full Text] [Related]
16. Re-examining the effects of high-dose intravenous methylprednisolone for secondary progressive multiple sclerosis.
Jalipa FGU; Espiritu AI; Pasco PMD
Neurodegener Dis Manag; 2021 Apr; 11(2):177-185. PubMed ID: 33703936
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
[TBL] [Abstract][Full Text] [Related]
19. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis.
Fierro B; Salemi G; Brighina F; Buffa D; Conte S; La Bua V; Piazza A; Savettieri G
Acta Neurol Scand; 2002 Mar; 105(3):152-7. PubMed ID: 11886356
[TBL] [Abstract][Full Text] [Related]
20. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
